No. Current scientific and clinical evidence does not show that cannabis improves mental health or treats common psychiatric disorders.
Major medical organizations and reviews in The Lancet Psychiatry and JAMA Network report no major benefits from THC or CBD for anxiety, depression, PTSD, ADHD, or bipolar disorder.
Key Risks and Harms
• Psychosis and schizophrenia: Regular use or high-THC cannabis can raise the risk of psychotic disorders, especially for younger people and those with a family history.
• Worsened symptoms: Using cannabis to self-treat may increase paranoia, anxiety, and depression.
• Dependence and withdrawal: Frequent use can lead to cannabis use disorder, tolerance, and withdrawal such as poor sleep, irritability, and low mood.
• Adolescent impact: Teenagers and young adults may be more vulnerable because their brains are still developing.
Where Cannabis Has Limited Evidence
Careful reviews find little proof that cannabis heals mental health conditions. Some limited or low-quality evidence suggests small effects on sleep length, cannabis withdrawal, or tics linked to Tourette’s syndrome.
• Treatment-resistant depression: Studies by groups such as Compass Pathways suggest that controlled psilocybin doses combined with therapy may quickly and lastingly reduce depression. The FDA has given psilocybin a “breakthrough therapy” designation for major depression and treatment-resistant depression.
• Anxiety and end-of-life distress: Research from the Johns Hopkins Center for Psychedelic and Consciousness Research suggests psilocybin may reduce existential anxiety, fear, and depression in people with life-threatening or terminal cancer.
• Addiction and substance use: Research suggests psilocybin-assisted therapy may help people change addictive behavior, including long-term smoking and alcohol or cocaine dependence.
• PTSD and OCD: Early and ongoing studies are examining whether psilocybin can change rigid thought patterns linked to PTSD and obsessive-compulsive disorder.